• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    More On BHRT

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Bioheart, Inc. (BHRT)

    -Other OTC
    0.00 0.00(0.00%) Nov 3, 3:59PM EST
    Prev Close:0.00
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:0.40
    Beta:0.50006
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.00 - 0.02
    Volume:0
    Avg Vol (3m):N/A
    Market Cap:2.44K
    P/E (ttm):N/A
    EPS (ttm):-0.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BHRT

    Comparison

    Symbol% ChgMkt Cap
    BHRT 0.00%2.44K
    ACTC 0.00%N/A
    BAXUp 2.03%20.03B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Bioheart, Inc. focuses on the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback